São Paulo will have cannabis-based medicine in the SUS

The law that guarantees the inclusion of cannabis-based medicines in the Unified Health System (SUS) in São Paulo was sanctioned today (31), with partial vetoes. The project was approved on December 21 at the Legislative Assembly of the State of São Paulo (Alesp) with a proposal by deputy Caio França (PSB). On social networks, the parliamentarian said that this is a victory for families “of autistic people, people with rare syndromes, Parkinson’s and other pathologies”. Yesterday (30), the deputy delivered a petition with 40,000 signatures, in addition to notes of support, to the governor of São Paulo, Tarcísio de Freitas. The new law had to be sanctioned or vetoed by this Friday (3). Partial vetoes, according to the government, relate to passages that do not comply with the 1988 Federal Constitution. The text will be sent to Alesp for consideration. The state government informed that a working group will be created to regulate the new law. “Professionals will be responsible for implementing, updating and reassessing the State Policy on Medicines Formulated Based on Cannabis”, he pointed out in a note. The measure “minimizes the financial impacts of judicialization and, above all, guarantees patient safety, considering effective therapeutic protocols approved by health authorities”. The importation of medicinal products made from cannabis was released in 2015 by the National Health Surveillance Agency (Anvisa). Medicines were only provided by the state government through a court decision.

Agência Brasil